Risk of thromboembolism with lymphoma: myth or reality?

Leuk Lymphoma. 2016 Dec;57(12):2736-2738. doi: 10.1080/10428194.2016.1204658. Epub 2016 Jul 5.

Authors

Kate L Burbury¹, Marliese Alexander^{1

2}, David A Westerman^{1

3}

Affiliations

¹ a Division of Cancer Medicine , Peter MacCallum Cancer Centre , East Melbourne , Melbourne , Australia.
² b Monash University , Clayton , Victoria , Australia.
³ c University of Melbourne , Parkville , Victoria , Australia.

PMID: 27379822
DOI: 10.1080/10428194.2016.1204658

No abstract available

MeSH terms

Chemoprevention / statistics & numerical data
Fibrinolytic Agents / therapeutic use
Humans
Incidence
Lymphoma / complications*
Lymphoma / epidemiology
Meta-Analysis as Topic
Risk Assessment
Risk Factors
Thromboembolism / epidemiology
Thromboembolism / etiology*
Thromboembolism / prevention & control

Substances

Fibrinolytic Agents